Savior Lifetec Corporation (4167.TWO)
TWD 15.9
(-9.92%)
TWD 15.9
(-9.92%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 860.04 Million TWD | -17.01% |
| 2022 | 1.03 Billion TWD | -20.73% |
| 2021 | 1.3 Billion TWD | 21.22% |
| 2020 | 1.07 Billion TWD | 26.92% |
| 2019 | 849.7 Million TWD | -15.96% |
| 2018 | 1.01 Billion TWD | 28.26% |
| 2017 | 788.31 Million TWD | 15.61% |
| 2016 | 681.86 Million TWD | 6.21% |
| 2015 | 642.02 Million TWD | 11.68% |
| 2014 | 574.87 Million TWD | 11.13% |
| 2013 | 517.28 Million TWD | -2.68% |
| 2012 | 531.53 Million TWD | -22.46% |
| 2011 | 685.46 Million TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 838.13 Million TWD | -2.55% |
| 2024 Q2 | 746.36 Million TWD | -10.95% |
| 2023 Q3 | 881.97 Million TWD | -12.82% |
| 2023 Q1 | 1.07 Billion TWD | 3.42% |
| 2023 Q2 | 1.01 Billion TWD | -5.61% |
| 2023 FY | 860.04 Million TWD | -17.01% |
| 2023 Q4 | 860.04 Million TWD | -2.49% |
| 2022 Q2 | 1.23 Billion TWD | -9.55% |
| 2022 Q3 | 1.08 Billion TWD | -12.18% |
| 2022 Q4 | 1.03 Billion TWD | -4.42% |
| 2022 Q1 | 1.36 Billion TWD | 4.42% |
| 2022 FY | 1.03 Billion TWD | -20.73% |
| 2021 Q3 | 1.38 Billion TWD | 28.66% |
| 2021 Q1 | 1.1 Billion TWD | 2.07% |
| 2021 Q2 | 1.07 Billion TWD | -2.15% |
| 2021 FY | 1.3 Billion TWD | 21.22% |
| 2021 Q4 | 1.3 Billion TWD | -5.66% |
| 2020 Q1 | 914.13 Million TWD | 7.58% |
| 2020 Q2 | 1 Billion TWD | 10.31% |
| 2020 Q3 | 1.05 Billion TWD | 4.98% |
| 2020 FY | 1.07 Billion TWD | 26.92% |
| 2020 Q4 | 1.07 Billion TWD | 1.88% |
| 2019 Q2 | 881.88 Million TWD | -7.08% |
| 2019 Q4 | 849.7 Million TWD | 1.35% |
| 2019 FY | 849.7 Million TWD | -15.96% |
| 2019 Q1 | 949.03 Million TWD | -6.14% |
| 2019 Q3 | 838.36 Million TWD | -4.94% |
| 2018 Q1 | 834.64 Million TWD | 5.88% |
| 2018 FY | 1.01 Billion TWD | 28.26% |
| 2018 Q4 | 1.01 Billion TWD | 7.51% |
| 2018 Q3 | 940.45 Million TWD | 9.02% |
| 2018 Q2 | 862.64 Million TWD | 3.35% |
| 2017 Q3 | 653.42 Million TWD | 4.08% |
| 2017 FY | 788.31 Million TWD | 15.61% |
| 2017 Q4 | 788.31 Million TWD | 20.64% |
| 2017 Q1 | 601.39 Million TWD | -11.8% |
| 2017 Q2 | 627.8 Million TWD | 4.39% |
| 2016 Q4 | 681.86 Million TWD | 3.71% |
| 2016 Q3 | 657.46 Million TWD | 5.09% |
| 2016 Q2 | 625.61 Million TWD | 3.99% |
| 2016 Q1 | 601.61 Million TWD | -6.29% |
| 2016 FY | 681.86 Million TWD | 6.21% |
| 2015 Q3 | 593.16 Million TWD | 4.89% |
| 2015 Q4 | 642.02 Million TWD | 8.24% |
| 2015 Q2 | 565.48 Million TWD | 3.91% |
| 2015 FY | 642.02 Million TWD | 11.68% |
| 2015 Q1 | 544.21 Million TWD | -5.33% |
| 2014 Q3 | 504.21 Million TWD | -10.62% |
| 2014 Q1 | - TWD | -100.0% |
| 2014 Q2 | 564.14 Million TWD | 0.0% |
| 2014 FY | 574.87 Million TWD | 11.13% |
| 2014 Q4 | 574.87 Million TWD | 14.01% |
| 2013 Q4 | 517.28 Million TWD | 0.0% |
| 2013 FY | 517.28 Million TWD | -2.68% |
| 2013 Q1 | 521.79 Million TWD | -1.83% |
| 2013 Q2 | 521.79 Million TWD | 0.0% |
| 2012 Q2 | 569.12 Million TWD | 0.0% |
| 2012 FY | 531.53 Million TWD | -22.46% |
| 2012 Q4 | 531.53 Million TWD | 0.0% |
| 2012 Q3 | 531.53 Million TWD | -6.61% |
| 2011 Q4 | 685.46 Million TWD | 0.0% |
| 2011 FY | 685.46 Million TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 459.97 Million TWD | -86.976% |
| Level Biotechnology Inc. | 88.85 Million TWD | -867.973% |
| Sagittarius Life Science Corp | 31.54 Million TWD | -2626.749% |
| NeoCore Technology Co., Ltd. | 66.38 Million TWD | -1195.618% |
| TaiMed Biologics Inc. | 1.26 Billion TWD | 32.022% |
| GlycoNex Incorporation | 17.4 Million TWD | -4841.93% |
| VBI | 10.03 Million TWD | -8470.443% |
| GeneReach Biotechnology Corp. | 67.37 Million TWD | -1176.522% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.17 Million TWD | -3962.368% |
| Visgeneer Inc. | 49.07 Million TWD | -1652.581% |
| Mycenax Biotech Inc. | 112.32 Million TWD | -665.668% |
| Sunmax Biotechnology Co., Ltd. | 93.67 Million TWD | -818.164% |
| G&E Herbal Biotechnology Co., Ltd. | 22.9 Million TWD | -3654.995% |
| Medigen Vaccine Biologics Corporation | 383.63 Million TWD | -124.183% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -4.78 Million TWD | 18058.739% |
| Enimmune corporation | 15.7 Million TWD | -5377.638% |
| TaiRx, Inc. | 11 Thousand TWD | -7818481.818% |
| CHO Pharma, Inc. | 1.00 TWD | -86004399900.0% |
| EirGenix Inc. | 680.63 Million TWD | -26.359% |
| BioLASCO Taiwan Co., Ltd. | 32.52 Million TWD | -2544.336% |
| Sunny Pharmtech Inc. | 97.03 Million TWD | -786.287% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 16.54 Million TWD | -5098.211% |
| Feng Chi Biotech Corp. | 19.03 Million TWD | -4417.75% |
| Bio Preventive Medicine Corp. | 1.23 Million TWD | -69370.436% |
| Lukas Biomedical Inc. | 36.72 Million TWD | -2241.849% |
| RBC Bioscience Corporation | 44.42 Million TWD | -1836.033% |
| BiOptic Inc. | 161.07 Million TWD | -433.95% |
| BRIM Biotechnology, Inc. | -6.23 Million TWD | 13887.175% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| Great Novel Therapeutics Biotech & Medicals | 6.16 Million TWD | -13859.487% |
| Syngen Biotech Co.,Ltd. | 348.98 Million TWD | -146.44% |
| Anti-Microbial Savior BioteQ Co., Ltd | 505 Thousand TWD | -170205.743% |
| SynCore Biotechnology Co.,Ltd | 3.12 Million TWD | -27439.033% |
| Genomics BioSci & Tech. Co.,Ltd. | 61.5 Million TWD | -1298.241% |
| Neith Corporation | 463 Thousand TWD | -185654.644% |
| Advagene Biopharma Co., Ltd. | -91.99 Thousand TWD | 934940.596% |
| NaviFUS Corp. | 6.87 Million TWD | -12413.371% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 12.16 Million TWD | -6968.08% |
| Sinew Pharma Inc. | -766 Thousand TWD | 112377.285% |
| Andros Pharmaceuticals Co.,Ltd | 1.08 Million TWD | -78948.162% |
| Greenyn Biotechnology Co., Ltd | 163.13 Million TWD | -427.194% |
| Lumosa Therapeutics Co., Ltd. | 103.91 Million TWD | -727.666% |
| AP Biosciences Inc | - TWD | -Infinity% |
| Medigen Biotechnology Corp. | 546.9 Million TWD | -57.256% |
| 3D Global Biotech Inc. | 3.59 Million TWD | -23823.338% |
| Pharmosa Biopharm Inc. | 21.9 Million TWD | -3825.528% |
| Intech Biopharm Corporation | 41.52 Million TWD | -1971.148% |
| Oneness Biotech Co., Ltd. | 122.73 Million TWD | -600.721% |
| Eusol Biotech Co.,Ltd. | -8.1 Million TWD | 10715.206% |
| TWi Biotechnology, Inc. | -435 Thousand TWD | 197811.264% |
| Ever Supreme Bio Technology Co., Ltd | 69.08 Million TWD | -1144.889% |
| TCI GENE Inc. | 54.84 Million TWD | -1468.078% |
| MegaPro Biomedical Co., Ltd | 20.51 Million TWD | -4093.291% |
| Senhwa Biosciences, Inc. | - TWD | -Infinity% |
| Taiwan Bio Therapeutics Co., Ltd | 40.96 Million TWD | -1999.512% |
| NatureWise Biotech & Medicals Corporation | 82.5 Million TWD | -942.478% |
| PharmaEngine, Inc. | 15.9 Million TWD | -5308.742% |
| TaiGen Biopharmaceuticals Holdings Limited | 34.15 Million TWD | -2418.136% |
| OBI Pharma, Inc. | 25.93 Million TWD | -3216.536% |
| Meribank Biotech Co., Ltd | 6.9 Million TWD | -12351.774% |
| Acepodia, Inc. | 39.52 Million TWD | -2075.784% |
| Caliway Biopharmaceuticals Co., Ltd. | 1.02 Million TWD | -83970.772% |